Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen Therapy Following Management of Soft Tissue Sarcoma
NCT03144206Phase 4Completed
- Sponsor
- Duke University
- Start
- Oct 2017
- Primary completion
- Sep 2026
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
A Phase 4 trial of hyperbaric oxygen therapy in soft tissue sarcoma (STS), sponsored by Duke University. Started Oct 2017; status: completed.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT03144206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03144206.